Surrozen, Inc./DE SEC filings SRZN
Surrozen, Inc./DE has 496 filings in SEC EDGAR's recent list, going back to Sep 18, 2020. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (results of operations, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Unregistered share sale
|
Oct 20, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Other events
|
Oct 2, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2026 | May 13, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 30, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Agreement ended
|
Oct 17, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 29, 2025 | Aug 29, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Mar 28, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 2, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 2, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Other events
|
Jan 18, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 13, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Dec 11, 2023 | Dec 7, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 13, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 19, 2023 | Jul 19, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 5, 2023 | Jul 5, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2023 | May 18, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 5, 2023 | Apr 5, 2023 |
| 8-K |
Current report
Other events
|
Mar 23, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Listing notice
|
Jan 5, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Other events
|
Dec 15, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 16, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Material agreement
|
Oct 6, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2022 | Mar 21, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 24, 2022 | Feb 18, 2022 |
| 8-K |
Current report
Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change
|
Aug 17, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 12, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Other events
|
Aug 2, 2021 | Aug 2, 2021 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure, Other events
|
Jul 30, 2021 | Jul 30, 2021 |
| 8-K |
Current report
Restatement, Other events
|
May 14, 2021 | May 13, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 15, 2021 | Apr 15, 2021 |
| 8-K |
Current report
Other events
|
Jan 7, 2021 | Jan 7, 2021 |
| 8-K |
Current report
Other events
|
Nov 30, 2020 | Nov 23, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 25, 2020 | Nov 23, 2020 |
Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SRZN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1824893
- Former names
- Consonance-HFW Acquisition Corp. (until Aug 11, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.